Resource Library

Topics

Filters

Clear Filters

Resource Library

New to the Resource Library?

Learn how to navigate, search, and use our resources effectively.

How to use the Library

U.S. substance use harm reduction efforts: A review of the current state of policy, policy barriers, and recommendations

Substance use disorders and overdose deaths are rising, significantly impacting the U.S. Fentanyl drives many overdoses, but other drug-related harms and infectious diseases are also increasing.

NaloxoneDrug checking equipmentSyringe service programsOverdose prevention centersMedications for opioid use disorderPre-exposure prophylaxis
(2025)

Inequities in Opioid Administration by Race and Ethnicity for Hospitalized Patients With and Without Substance Use Disorders

Minority patients with substance use disorders received fewer daily opioid doses for pain management during hospitalization. This disparity remained even after accounting for various clinical and demographic factors.

health equitypain management substance use disordershospital medicinehospitalmedicine
(2025)

Helping Opioid Use Disorder and PTSD with Exposure (HOPE): An Open-Label Pilot Study of a Trauma-Focused, Integrated Therapy for OUD/PTSD

Opioid use disorder and posttraumatic stress disorder often occur together, making treatment complex. New integrated psychotherapies are needed for individuals with both conditions to improve treatment outcomes.

opioid use disorderposttraumatic stress disorderPTSDintegrated treatmentexposure therapy
(2025)

Exploring Social Impairment in Those With Opioid Use Disorder: Linking Impulsivity, Childhood Trauma, and the Prefrontal Cortex

Opioid use disorder is a major public health issue, with nearly 80% of drug-related deaths linked to opioids. Impulsivity and childhood adversity are risk factors that can impact treatment and recovery.

opioid use disordersocial functioningimpulsivitychildhood traumaprefrontal cortexbrainbehaviorACEs
(2025)

Promising Opportunities to Intervene on Adolescent Substance Use

Drug overdose deaths and non-medical prescription drug use have declined among adolescents. Illicit drug, cannabis, alcohol, and nicotine vaping also decreased, though adolescent substance use disorder remains a concern.

Substance useadolescentsprescription opioidsstimulantsADHDcannabis use disorderoverdose
(2025)

N-acetylcysteine for youth cannabis use disorder: Randomized controlled trial main findings

A study found N-acetylcysteine, an over-the-counter supplement, helped young people aged 14–21 reduce cannabis use when combined with brief counseling. This effect was not observed in adults.

Cannabis use disorder N-acetylcysteineYouthAdolescent cannabis useClinical trialContingency management
(2025)

Developmental differences in social information use under uncertainty: A neurocomputational approach

Adolescents are more influenced by peers due to increased uncertainty in new situations. They learn to weigh peer information based on their own knowledge and the peer's perceived expertise.

DevelopmentAdolescenceSocial learningUncertaintydecision-makingNeuroimagingMetacognition
(2025)

"Sex-specific differences in brain activity dynamics of youth with a family history of substance use disorder "

A family history of substance use disorder (SUD) and an individual's sex influence their vulnerability to SUD.

(2025)

From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS)

The study found that psilocybin reduced confidence in negative self-beliefs, both immediately and weeks later. This suggests psychedelics could help revise unhelpful thought patterns and improve well-being.

Psychedelic therapyREBUS modelneural entropypsilocybinwell-being
(2025)

Neurobiological intersections of stress and substance use disorders

Substance Use Disorders (SUDs) are brain diseases characterized by compulsive drug seeking despite negative consequences. Stress significantly contributes to SUD development and relapse by impacting brain reward and stress systems.

HPA axisneuroinflammationearly life stressmood disorderssubstance use disorder
(2025)

Efficacy and Clinical Application of Physical Activity in Substance Use Disorder Rehabilitation: A Review on Mechanism and Benefits

Physical activity (PA) offers a comprehensive approach to treating substance use disorders (SUDs) by enhancing brain function, reducing cravings, and improving mood. Regular PA supports long-term recovery and overall well-being.

substance use disordersphysical activityrelapse preventioncraving reductionmental healthrehabilitation
(2025)

The role of personality functioning and childhood trauma in patients in opioid substitution treatment

The study found that individuals with opioid use disorders in a substitution program have significant impairments in personality functioning, which are linked to childhood trauma and injecting drug use.

personality functioningsubstance use disordersopioid use disordersinjecting drug usechildhood trauma
(2025)

Novel Insights into Addiction Management: A Meta-Analysis on Intervention for Relapse Prevention

Addiction is a chronic brain disorder, and relapse rates for substance use remain high after treatment. This analysis explores recent developments in preventing relapse from alcohol and drug addiction.

addictionrelapse preventionpharmacological interventionnon-pharmacological interventiondetoxification
(2025)

Exploration of Effective Substance Use Relapse Prevention Programmes for the Youth: An Integrative Literature Review

Many young people with substance use disorders relapse after treatment. Effective relapse prevention programs, considering social and cultural factors, are crucial for supporting long-term recovery in youth.

check-upspreventionprogrammerelapsesubstance use
(2025)

MDMA and MDMA-Assisted Therapy

Studies show MDMA-Assisted Therapy effectively treats PTSD, but the FDA requires further research before approval. It's crucial to distinguish between clinical MDMA therapy and recreational MDMA use.

MDMAMDMA-Assisted TherapyPosttraumatic Stress Disorder (PTSD)Mental Health Treatment
(2025)